Glaxo boosted by US patent ruling on anti-depressant drug

Glaxosmithkline raised hopes it could head off potential rivals to one of its top-selling drugs yesterday and reassured investors by repeating its earnings guidance.

Europe's biggest drug maker said a US judge had ruled in its favour on one patent related to its anti-depressant drug Paxil, but had also decided in favour of the private Canadian company Apotex on another.

The company said the judge for the Eastern District of Pennsylvania had split the decision on the remaining two disputed patents, holding some claims in the patents invalid and denying Apotex's motions on others.

GSK, which is battling against cheap generic versions of its blockbuster drugs, said it would seek an appeal against the ruling that one patent was invalid. The dispute over the remaining three patents will go forward to a court case.

"Glaxo continues to believe there are significant hurdles that prevent launch of a generic Paxil product," the company said. "Accordingly, Glaxo's published earnings guidance for 2002 and 2003 remains as previously stated."

The company expects to deliver growth in earnings per share of at least 10 per cent in 2002 and high single-digits in 2003, assuming it successfully defends its Paxil patents.

Steve Plag, pharmaceuticals analyst at Credit Suisse First Boston, said: "This is clearly very good news as it means the second patent case now goes to trial in one of the slowest courts in the US, which should mean no resolution to the Paxil case until the end of 2003 at the earliest."

The shares rose 27p to 1,147p.

Paxil, which belongs to the same class of anti-depressants as Prozac, sold by Eli Lilly, has been a huge commercial success for GSK, generating global sales of £1.86bn last year.

Another analyst said the news was mildly positive for GSK. "If they had lost all four patents, Apotex would probably have just launched their product.... This was potentially very negative and that's been removed now for another six months," the analyst said.

Glaxo is also pursuing another case against Apotex in Chicago over its patent covering the hemihydrate form of Paxil, which expires in 2006.

PROMOTED VIDEO
News
ebooksAn evocation of the conflict through the eyes of those who lived through it
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Client Services Executive / Account Executive - SW London

£23000 - £26000 per annum: Ashdown Group: Account Executive / Client Services ...

PA to CEO / Executive Secretary

£36000 - £38000 per annum: Ashdown Group: Executive PA to CEO & Executive Dire...

Generalist HR Administrator, Tunbridge Wells, Kent - £28,000.

£25000 - £28000 per annum: Ashdown Group: Generalist HR Administrator - Tunbri...

Management Accountant

£30-35k + Excellent Benefits: Guru Careers: We are seeking a Management Accoun...

Day In a Page

Kate Bush, Hammersmith Apollo music review: A preamble, then a coup de théâtre - and suddenly the long wait felt worth it

Kate Bush shows a voice untroubled by time

A preamble, then a coup de théâtre - and suddenly the long wait felt worth it
Robot sheepdog technology could be used to save people from burning buildings

The science of herding is cracked

Mathematical model would allow robots to be programmed to control crowds and save people from burning buildings
Tyrant: Is the world ready for a Middle Eastern 'Dallas'?

This tyrant doesn’t rule

It’s billed as a Middle Eastern ‘Dallas’, so why does Fox’s new drama have a white British star?
Rachael Lander interview: From strung out to playing strings

From strung out to playing strings

Award-winning cellist Rachael Lander’s career was almost destroyed by the alcohol she drank to fight stage fright. Now she’s playing with Elbow and Ellie Goulding
The science of saturated fat: A big fat surprise about nutrition?

A big fat surprise about nutrition?

The science linking saturated fats to heart disease and other health issues has never been sound. Nina Teicholz looks at how governments started advising incorrectly on diets
Emmys 2014 review: Can they genuinely compete with the Oscars

Can they genuinely compete with the Oscars?

The recent Emmy Awards are certainly glamorous, but they can't beat their movie cousins
On the road to nowhere: A Routemaster trip to remember

On the road to nowhere

A Routemaster trip to remember
Hotel India: Mumbai's Taj Mahal Palace leaves its darker days behind

Hotel India

Mumbai's Taj Mahal Palace leaves its darker days behind
10 best pencil cases

Back to school: 10 best pencil cases

Whether it’s their first day at school, uni or a new project, treat the student in your life to some smart stationery
Arsenal vs Besiktas Champions League qualifier: Gunners know battle with Turks is a season-defining fixture

Arsenal know battle with Besiktas is a season-defining fixture

Arsene Wenger admits his below-strength side will have to improve on last week’s show to pass tough test
Pete Jenson: Athletic Bilbao’s locals-only transfer policy shows success does not need to be bought

Pete Jenson: A Different League

Athletic Bilbao’s locals-only transfer policy shows success does not need to be bought
This guitar riff has been voted greatest of all time

The Greatest Guitar Riff of all time

Whole Lotta Votes from Radio 2 listeners
Britain’s superstar ballerina

Britain’s superstar ballerina

Alicia Markova danced... every night of the week and twice on Saturdays
Berlin's Furrie invasion

Berlin's Furrie invasion

2000 fans attended Eurofeurence
‘It was a tidal wave of terror’

‘It was a tidal wave of terror’

Driven to the edge by postpartum psychosis